A Second Look: Reanalysis of the Pediatric Heart Network Marfan Trial Data to Assess the Effects of Losartan and Atenolol on Disease Progression Using Aortic Cross-Sectional Area/Height
- 10 March 2026
- journal article
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 39 (6) , 619-621
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Is Aortic Z-score an Appropriate Index of Beneficial Drug Effect in Clinical Trials in Aortic Aneurysm Disease?The American Journal of Cardiology, 2021
- The impact of body weight on the diagnosis of aortic dilation—misdiagnosis in overweight and underweight groupsEchocardiography, 2017
- Aortic Cross-Sectional Area/Height Ratio and Outcomes in Patients With a Trileaflet Aortic Valve and a Dilated AortaCirculation, 2016
- Atenolol versus Losartan in Children and Young Adults with Marfan's SyndromeNew England Journal of Medicine, 2014
- Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapyAmerican Heart Journal, 2013
- Echocardiographic Methods, Quality Review, and Measurement Accuracy in a Randomized Multicenter Clinical Trial of Marfan SyndromeJournal of the American Society of Echocardiography, 2013